Starnberg, July 1, 2023
Dr Frank Bredl will take over the position of President of PARI GmbH from Jürgen Müller on 1st July, 2023. Jürgen Müller will continue to lead the businesses of PARItec and PARI Medical Holding as President.
Dr Bredl studied communication sciences, economic policy and psychology. He has been Vice President of Marketing and Corporate Communication at PARI since November 2022. Before moving to PARI, Dr Bredl held various marketing and sales positions at AstraZeneca and Bayer in Germany and the USA.
Arne W. Dirks, CEO of the PARI Group, is looking forward to the continuing collaboration: “Dr Bredl has been able to set important impulses during the short time he has been with the company. I am convinced that he will successfully lead PARI GmbH into the future and identify new growth opportunities.”
“I am looking forward to my new assignment. PARI products enjoy the trust of doctors, pharmacists and patients worldwide. To keep it that way, we have to further develop our portfolio in line with the needs of our customers”, said Dr Bredl while being handed over the business of PARI GmbH. In doing so, he wants to place a special focus on topics such as sustainability, digitisation and e-commerce, continued Dr Bredl.
Download this article as a PDF
Dr Frank Bredl is the new President of PARI GmbH
Dr Frank Bredl is the new President of PARI GmbH
As a manufacturer of medical devices with a focus on inhalation devices, PARI is the market leader in Germany, having established itself over decades as a trusted brand among doctors, pharmacies and patients, while its success in the cystic fibrosis segment has positioned the company as world market leader.
PARI was founded in Wuppertal in 1906 and now has its headquarters in Starnberg. Always an independent and privately owned company, the PARI Group is under the umbrella of PARI Medical Holding with CEO Arne W. Dirks and is organized into several subsidiaries.
In addition, there are international branch offices and a worldwide distribution network.
With a workforce of around 650 and a management team that has been stable for many years, the company can look back on a history of more than 100 years in business. It is where tradition and innovation meet to deliver well thought-out and effective product lines with an excellent reputation. Clinically proven, tried and tested nebulisers and inhalation devices made in Germany with affirmed performance have been used in countless pivotal studies and have won over medical specialists and users for decades.
Among the most well-known products are the PARI BOY®, which is synonymous with inhalation therapy and has been on the market for over 50 years and is on its 8th generation, as well as the eFlow®rapid nebuliser based on vibrating membrane technology supplemented by a multitude of drug-specific applications in respiratory diseases.
PARI Medical Holding GmbH
Public Relations
Moosstrasse 3, 82139 Starnberg
GERMANY
Tel.: 0049 8151 279 0
Fax: 0049 8151 279 6119
Email: publicrelationspari.com
© 2024 PARI GmbH Spezialisten für effektive Inhalation
